ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 609,15
-0,69%
Dow Jones
39 127,80
0,04%
DAX
18 155,24
-0,04%
Brent Oil
84,285
-0,22%
Bitcoin
61 065,61
0,42%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Dova Pharmaceuticals Inc (DOVA)

  7. Dova Pharmaceuticals Inc (DOVA) Actualités

DOVA

Dova Pharmaceuticals (DOVA)

Dova Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:DOVA
DateHeureSourceTitreSymboleSociété
22/11/201922h13Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:DOVADova Pharmaceuticals Inc
19/11/201912h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:DOVADova Pharmaceuticals Inc
18/11/201912h02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DOVADova Pharmaceuticals Inc
12/11/201922h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DOVADova Pharmaceuticals Inc
12/11/201915h44Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:DOVADova Pharmaceuticals Inc
12/11/201915h35Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:DOVADova Pharmaceuticals Inc
12/11/201915h33Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:DOVADova Pharmaceuticals Inc
12/11/201915h30Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:DOVADova Pharmaceuticals Inc
12/11/201915h26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DOVADova Pharmaceuticals Inc
12/11/201915h19Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:DOVADova Pharmaceuticals Inc
12/11/201912h07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DOVADova Pharmaceuticals Inc
17/10/201917h23PR Newswire (US)Moore Kuehn, PLLC Encourages Milacron Holdings Corp. (MCRN), Ecology & Environmental, Inc. (EEI), Pivotal Software, Inc. (PVT...NASDAQ:DOVADova Pharmaceuticals Inc
11/10/201923h16Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:DOVADova Pharmaceuticals Inc
11/10/201923h09Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:DOVADova Pharmaceuticals Inc
05/10/201900h12PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Dova Pharmaceuticals, Inc.NASDAQ:DOVADova Pharmaceuticals Inc
03/10/201922h10Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:DOVADova Pharmaceuticals Inc
01/10/201923h13Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:DOVADova Pharmaceuticals Inc
30/09/201915h57PR Newswire (US)Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Dova Pharmaceuticals, Inc. has obtained a Fair Price in its sal...NASDAQ:DOVADova Pharmaceuticals Inc
30/09/201908h00GlobeNewswire Inc.Dova Pharmaceuticals to be Acquired by Swedish Orphan Biovitrum AB (Sobi)NASDAQ:DOVADova Pharmaceuticals Inc
25/09/201922h15GlobeNewswire Inc.Dova Pharmaceuticals to Present at 2019 Cantor Global Healthcare ConferenceNASDAQ:DOVADova Pharmaceuticals Inc
03/09/201922h30GlobeNewswire Inc.Dova Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:DOVADova Pharmaceuticals Inc
06/08/201922h15GlobeNewswire Inc.Dova Pharmaceuticals to Present at 2019 Wedbush PacGrow Healthcare ConferenceNASDAQ:DOVADova Pharmaceuticals Inc
06/08/201913h00GlobeNewswire Inc.Dova Pharmaceuticals Reports Second Quarter 2019 Operating and Financial ResultsNASDAQ:DOVADova Pharmaceuticals Inc
30/07/201922h15GlobeNewswire Inc.Dova Pharmaceuticals to Announce Second Quarter 2019 Financial Results on August 6, 2019NASDAQ:DOVADova Pharmaceuticals Inc
19/07/201913h30GlobeNewswire Inc.Dova Pharmaceuticals Announces DOPTELET® (avatrombopag) Now Commercially Available in the United States for Treatment of Chr...NASDAQ:DOVADova Pharmaceuticals Inc
27/06/201914h05GlobeNewswire Inc.Dova Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for DOPTELET® (avatrombopag) for Treatment...NASDAQ:DOVADova Pharmaceuticals Inc
25/06/201914h00GlobeNewswire Inc.Dova Pharmaceuticals Announces European Union Marketing Authorization for DOPTELET® (avatrombopag) for the Treatment of Thro...NASDAQ:DOVADova Pharmaceuticals Inc
24/06/201914h00GlobeNewswire Inc.Dova Pharmaceuticals Announces Four Presentations on Avatrombopag in Patients with Chronic Immune Thrombocytopenia at the Int...NASDAQ:DOVADova Pharmaceuticals Inc
28/05/201922h30GlobeNewswire Inc.Dova Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare ConferenceNASDAQ:DOVADova Pharmaceuticals Inc
23/05/201915h06PR Newswire (US)Wedbush Securities Senior Vice President of Equity Research Laura Chico, Ph.D. Initiates Coverage on Six Stocks in the Health...NASDAQ:DOVADova Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:DOVA

Dernières Valeurs Consultées

AMEX
DIM
WisdomTree International...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés